Mind Medicine Inc (NAS:MNMD)
$ 8.17 -0.09 (-1.09%) Market Cap: 599.12 Mil Enterprise Value: 328.15 Mil PE Ratio: 0 PB Ratio: 2.54 GF Score: 41/100

Mind Medicine (MindMed) Inc at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 13, 2023 / 06:00PM GMT
Release Date Price: $3.03 (+0.66%)
Frank Brisebois
Oppenheimer & Co. Inc. - Analyst

Okay. All right. Thanks for joining this afternoon, Oppenheimer Healthcare Conference. I know it's been a very busy time for a lot of people, so I appreciate the time.

Next presenter here we have Rob Barrow, who is CEO of Mind Med. Just full disclosure, we cover Mind Med at Oppenheimer. I'm Frank Brisebois, one of the senior biotech analysts at the firm.

And with that, Rob, thanks for joining, I think what would be helpful in terms of format, we'll just do a fireside chat. I think it would be most helpful is just maybe to those that aren't familiar, just an overview of the company.

Rob Barrow;MindMed;Inc.;CEO;Board Director
Mind Medicine

()-&

Yeah. Thanks so much, Frank. Thanks for having us here. So to give high-level overview. We're a company headquartered in New York. It's developing the psychedelic drug class. And we've taken a particularly unique approach and the opportunity of developing these molecules. And it's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot